≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Examination and encounter for administrative purposes

DOID Endpoint Browser

Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z02
  • Cause of death: ICD-10 — Z02

2 out of 7 registries used, show all original rules.

1701

4. Check minimum number of events

None

1701

5. Include endpoints

None

1701

6. Filter based on genotype QC (FinnGen only)

1701

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[0-1]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1701 636 1065
Unadjusted period prevalence (%) 0.38 0.22 0.47
Median age at first event (years) 65.67 58.50 69.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1416
Matched controls
14160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z02.4
ICD-10 Finland
Examination for driving licence
9.8
323.0
1034
3050
Z01.8
ICD-10 Finland
Other specified special examinations
11.1
130.3
263
286
Z02.7
ICD-10 Finland
Issue of medical certificate
8.5
106.5
249
345
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
47.1
95.7
117
27
Z01.0
ICD-10 Finland
Examination of eyes and vision
13.4
88.8
160
133
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
8.5
85.7
199
268
Z02.8
ICD-10 Finland
Other examinations for administrative purposes
34.6
83.5
109
34
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
403.5
77.6
77
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
11.8
68.4
130
120
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
98.8
60.4
66
7
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
20.0
44.3
67
35
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.4
41.6
114
191
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
29.9
38.9
52
18
Z02.9
ICD-10 Finland
Examination for administrative purposes, unspecified
65.0
33.1
38
6
N02BE01
ATC
paracetamol; systemic, rectal
2.1
30.4
1136
9276
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.7
29.6
105
238
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
27.5
552
3530
N05AH04
ATC
quetiapine; oral
2.6
24.9
199
838
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
91.7
24.7
27
*
SPAT1153
SPAT
Removal of sutures
1.9
23.7
438
2683
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
30.6
22.8
30
10
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
21.3
352
2057
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
13.1
21.2
37
29
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
21.2
307
1702
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
21.2
501
3311
UJF32
NOMESCO Finland
Coloscopy
2.1
21.0
288
1563
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.6
21.0
99
292
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
10.3
20.9
41
41
Z00.0
ICD-10 Finland
General medical examination
2.5
20.1
170
735
SPAT1312
SPAT
General health counselling
1.8
19.8
447
2894
N03AX12
ATC
gabapentin; oral
2.4
19.7
180
811
KMAK
NOMESCO Finland
NA
1.7
19.6
632
4562
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
18.7
550
3847
XA402
NOMESCO Finland
ENMG
10.8
18.5
35
33
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.4
17.6
86
261
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
17.3
285
1648
-1
NOMESCO Finland
NA
1.8
17.2
398
2574
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.8
17.2
58
126
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
17.2
862
6918
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
17.1
384
2462
R51.80
ICD-10 Finland
Headache
2.4
16.9
149
654
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.3
16.7
51
99
S18
ICPC
Laceration/cut
1.7
16.7
506
3541
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
16.6
789
6214
Z02.1
ICD-10 Finland
Pre-employment examination
8.5
16.3
35
42
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.9
15.8
101
370
N03AX09
ATC
lamotrigine; oral
4.1
15.7
61
153
Z02.5
ICD-10 Finland
Examination for participation in sport
161.6
15.5
16
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
15.5
132
572
M54.5
ICD-10 Finland
Low back pain
1.7
15.2
359
2323
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
15.0
445
3074
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
14.9
573
4234
N03AX16
ATC
pregabalin; oral
1.9
14.7
248
1439
WX110
NOMESCO Finland
Local anesthesy
1.6
14.6
861
7047
P19
ICPC
Drug abuse
12.0
14.6
26
22
Z00.8
ICD-10 Finland
Other general examinations
3.2
14.4
77
251
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
14.4
444
3095
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
27.5
14.3
19
7
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
14.2
641
4911
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
14.2
332
2138
SPAT1301
SPAT
No procedures
1.7
14.2
394
2666
K02.1
ICD-10 Finland
Caries of dentine
1.5
14.1
688
5361
N06AX16
ATC
venlafaxine; oral
2.3
14.1
136
624
M79.6
ICD-10 Finland
Pain in limb
1.7
14.1
392
2655
SPAT1310
SPAT
Counselling related to known health issue
1.7
13.9
383
2583
N06AX11
ATC
mirtazapine; oral
1.7
13.8
332
2154
N07BB01
ATC
disulfiram; oral
3.3
13.8
71
226
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
13.7
301
1903
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.8
13.6
38
67
H02AB06
ATC
prednisolone; systemic
1.6
13.5
518
3803
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
13.2
652
5068
SPAT1240
SPAT
Therapeutic discussion
2.4
13.1
119
531
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
13.0
56
155
Z97.4
ICD-10 Finland
Presence of external hearing-aid
5.0
13.0
41
84
T89
ICPC
Diabetes insulin dependent
3.9
13.0
53
140
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
19.2
12.9
19
10
AA1AD
NOMESCO Finland
CT of head and brain
1.7
12.8
274
1712
N02AX02
ATC
tramadol; systemic, rectal
1.6
12.8
480
3490
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.6
12.7
29
39
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
12.6
122
565
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.9
12.5
184
1010
Z04.3
ICD-10 Finland
Examination and observation following other accident
+∞
12.5
12
*
A02BC02
ATC
pantoprazole; systemic
1.5
12.4
733
5896
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
6.6
12.3
31
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
12.3
508
3773
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.3
12.3
45
108
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
37.9
12.2
15
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
12.2
170
917
SPAT1254
SPAT
Administration of medicine
2.0
12.2
168
902
SPAT1263
SPAT
Sampling
1.5
12.2
505
3752
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.2
12.0
120
563
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.4
11.9
57
173
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
11.8
200
1157
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.7
11.7
29
44
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
5.1
11.7
36
72
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.6
11.7
85
339
N06AB04
ATC
citalopram; systemic
1.8
11.7
212
1253
R05
ICPC
Cough
1.7
11.6
244
1511
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
11.6
162
875
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
9.3
11.5
23
25
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
11.4
217
1302
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
11.4
79
305
N03AG01
ATC
valproic acid; systemic, rectal
2.8
11.4
71
258
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
11.4
175
977
A02BC05
ATC
esomeprazole; systemic
1.6
11.4
421
3034
N06AB10
ATC
escitalopram; oral
1.9
11.4
189
1084
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.0
11.3
44
112
M25.5
ICD-10 Finland
Pain in joint
1.7
11.3
291
1911
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
11.3
309
2066
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
11.2
334
2281
S06.0
ICD-10 Finland
Concussion
2.2
11.2
117
559
A02BC03
ATC
lansoprazole; oral
1.6
11.1
305
2036
J01DB01
ATC
cefalexin; oral
1.5
11.1
1017
8883
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
11.1
468
3469
A98
ICPC
Health maint/preventive medicine
2.0
11.1
1318
12339
R03AC02
ATC
salbutamol; inhalant
1.5
10.9
564
4368
N05AH03
ATC
olanzapine; systemic
2.8
10.9
69
254
Z01.9
ICD-10 Finland
Special examination, unspecified
3.1
10.9
58
191
G44.2
ICD-10 Finland
Tension-type headache
2.1
10.8
128
648
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.2
10.8
107
500
N06AA09
ATC
amitriptyline; systemic
2.3
10.7
100
455
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
10.7
134
693
Z72.2
ICD-10 Finland
Drug use
17.9
10.7
16
9
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
10.7
526
4030
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
10.6
82
339
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
10.6
670
5400
WZA90
NOMESCO Finland
Other doctors statement
1.7
10.6
250
1602
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
10.6
206
1246
G47.3
ICD-10 Finland
Sleep apnoea
1.7
10.5
236
1488
M01AH05
ATC
etoricoxib; oral
1.5
10.5
671
5415
J01AA02
ATC
doxycycline; systemic
1.5
10.5
932
8030
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.5
10.5
83
345
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
+∞
10.4
10
*
EBA00
NOMESCO Finland
Extraction of tooth
1.5
10.4
386
2772
XQ800
NOMESCO Finland
Prick test
3.2
10.4
54
175
N06AX21
ATC
duloxetine; oral
2.3
10.3
96
433
N05AA02
ATC
levomepromazine; systemic
3.2
10.3
53
170
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
10.2
176
1022
L08
ICPC
Shoulder symptom/complaint
1.7
10.2
206
1259
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.5
10.2
81
338
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
10.2
85
367
J01FF01
ATC
clindamycin; systemic
1.6
10.1
299
2031
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
10.1
85
368
M48.0
ICD-10 Finland
Spinal stenosis
2.0
10.0
128
668
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
10.0
440
3278
P29
ICPC
Psychological sympt/compl other
2.8
9.9
64
239
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
9.9
115
576
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
9.9
106
514
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.3
9.9
25
40
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.4
9.9
80
340
J02AC01
ATC
fluconazole; systemic
1.5
9.8
350
2486
WX290
NOMESCO Finland
Other blockade of nerve
1.5
9.8
507
3908
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
9.7
149
829
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.6
9.5
41
116
M79.1
ICD-10 Finland
Myalgia
2.0
9.4
128
683
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.4
430
3222
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
9.4
88
401
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
21.8
9.4
13
6
A10AE04
ATC
insulin glargine; parenteral
2.1
9.3
106
525
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
9.3
184
1116
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
9.3
85
383
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
9.3
43
128
L03
ICPC
Low back symptom/complaint
1.6
9.3
235
1530
R06.0
ICD-10 Finland
Dyspnoea
1.6
9.2
250
1656
N05CF01
ATC
zopiclone; oral
1.5
9.1
338
2417
P01
ICPC
Feeling anxious/nervous/tense
2.1
9.1
96
463
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
8.4
9.1
19
23
P74
ICPC
Anxiety disorder/anxiety state
4.0
9.0
35
90
K04.08
ICD-10 Finland
Other specified pulpit
2.4
9.0
74
317
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
9.0
353
2559
Z01.2
ICD-10 Finland
Dental examination
1.5
8.9
446
3397
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
8.9
234
1537
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.7
8.9
29
63
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
24.2
8.9
12
5
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
8.9
68
281
M03BX02
ATC
tizanidine; oral
1.4
8.8
668
5496
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
8.8
107
548
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
6.4
8.8
22
35
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
8.8
93
448
R53
ICD-10 Finland
Malaise and fatigue
1.7
8.8
196
1231
N06AB06
ATC
sertraline; oral
2.0
8.7
104
527
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.5
8.7
64
259
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
8.7
176
1074
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
8.7
178
1093
-69
ICPC
Other reason for encounter NEC
2.9
8.7
51
181
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.5
8.6
39
115
XCH00
NOMESCO Finland
Eye pressure measurement
3.2
8.6
43
137
R05
ICD-10 Finland
Cough
1.7
8.6
199
1265
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
8.5
98
489
M03AX01
ATC
botulinum toxin; parenteral
10.1
8.5
16
16
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.3
8.5
30
71
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
20.1
8.5
12
6
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
8.5
82
382
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
8.4
151
888
N05AX12
ATC
aripiprazole; systemic
3.3
8.4
41
128
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
8.4
274
1898
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
8.4
849
7329
P01AB01
ATC
metronidazole; oral, rectal
1.5
8.4
390
2923
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
8.3
231
1540
N05BA01
ATC
diazepam; systemic, rectal
1.9
8.3
130
730
3007
Kela drug reimbursment
Erenumab and fremanezumab
10.8
8.3
15
14
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
8.3
99
505
X58
ICD-10 Finland
Exposure to other specified factors
1.8
8.3
151
894
R03BA05
ATC
fluticasone; inhalant
1.7
8.3
179
1117
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.3
8.3
73
326
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
8.2
420
3200
DFF00
NOMESCO Finland
Pure tone audiometry
2.5
8.2
61
249
N06AA12
ATC
doxepin; systemic
2.5
8.1
60
244
P76
ICPC
Depressive disorder
2.6
8.1
57
226
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.2
8.1
17
21
F60.9
ICD-10 Finland
Personality disorder, unspecified
6.9
8.1
19
28
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
8.1
172
1065
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
9.0
8.0
16
18
P15
ICPC
Chronic alcohol abuse
3.1
8.0
41
133
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
22.1
8.0
11
5
Y96.9
ICD-10 Finland
Unspecified type of accident
5.3
8.0
23
44
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
4.8
7.9
25
53
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
7.9
46
162
N41.1
ICD-10 Finland
Chronic prostatitis
3.3
7.9
38
118
N06AB05
ATC
paroxetine; oral
2.4
7.9
65
281
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
7.9
46
163
P99
ICPC
Psychological disorders other
3.8
7.9
31
82
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.7
7.8
25
54
N05BA04
ATC
oxazepam; oral
1.6
7.8
228
1538
S29
ICPC
Skin symptom/complaint other
1.7
7.8
173
1087
Z50.1
ICD-10 Finland
Other physical therapy
2.6
7.7
54
214
M01AE02
ATC
naproxen; oral, rectal
1.4
7.7
623
5147
N06AX12
ATC
bupropion; oral
2.5
7.7
56
225
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
7.6
62
263
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.6
203
1338
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
8.1
7.6
16
20
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.7
7.6
18
27
J01EA01
ATC
trimethoprim; systemic
1.6
7.5
211
1409
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
7.5
72
332
A03
ICPC
Fever
1.7
7.5
154
944
J01CA04
ATC
amoxicillin; systemic
1.4
7.4
982
8770
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.5
7.4
18
28
Z02
ICD-10 Finland
Examination and encounter for administrative purposes
7.7
7.4
16
21
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.1
7.4
27
67
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
13.4
7.4
12
9
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.2
7.4
69
316
SFA00
NOMESCO Finland
Small filling
1.8
7.3
131
771
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.7
7.3
47
176
XKD00
NOMESCO Finland
Uroflowmetry
1.6
7.3
217
1470
P03
ICPC
Feeling depressed
2.1
7.3
78
380
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
7.3
89
458
L01
ICPC
Neck symptom/complaint
1.8
7.2
125
728
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
5.8
7.2
19
33
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
7.2
82
412
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
30.1
7.1
9
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
20.1
7.1
10
5
N06AB03
ATC
fluoxetine; oral
1.8
7.1
120
691
A04
ICPC
Weakness/tiredness general
1.8
7.1
115
656
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
8.8
7.0
14
16
LAA06
NOMESCO Finland
Transvaginal puncture of ovarian cyst
10.1
7.0
13
13
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
7.0
1134
10428
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
6.9
69
327
ZXA00
NOMESCO Finland
Right side
1.5
6.9
286
2079
M01AC06
ATC
meloxicam; systemic, rectal
1.4
6.9
369
2821
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.8
6.9
41
148
H3603, E103
ICD-10 Finland
NA
7.6
6.9
15
20
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
6.9
519
4212
Z56.7
ICD-10 Finland
Other and unspecified problems related to employment
13.8
6.9
11
8
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
6.8
109
618
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
6.8
202
1362
SPAT1325
SPAT
Vaccination
1.4
6.8
424
3329
K22
ICPC
Risk factor cardiovascular disease
2.3
6.8
58
257
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.8
178
1168
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
40.2
6.8
8
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.5
6.8
51
211
XCW10
NOMESCO Finland
Assessment of vision
16.8
6.7
10
6
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
6.7
106
597
Z29
ICPC
Social problem NOS
4.3
6.7
23
54
L12
ICPC
Hand/finger symptom/complaint
1.7
6.7
140
862
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.7
162
1038
H04AA01
ATC
glucagon; nasal, parenteral
3.6
6.7
28
79
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
6.7
78
393
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
6.7
74
367
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
22.6
6.7
9
*
J01MA12
ATC
levofloxacin; systemic
1.6
6.7
196
1322
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.2
6.7
62
285
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
4.9
6.7
20
41
A02BC01
ATC
omeprazole; systemic
1.5
6.7
283
2071
SPAT1043
SPAT
Audiometry
1.8
6.6
113
656
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.9
6.6
38
132
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.6
146
916
L17
ICPC
Foot/toe symptom/complaint
1.5
6.6
252
1802
G43.3
ICD-10 Finland
Complicated migraine
5.5
6.6
18
33
N01
ICPC
Headache
1.9
6.6
92
498
H13
ICPC
Plugged feeling ear
1.6
6.6
198
1341
R96
ICPC
Asthma
2.0
6.6
78
398
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
3.1
6.6
33
107
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.0
6.6
36
124
N02CD03
ATC
fremanezumab; systemic
12.3
6.6
11
9
N05AN01
ATC
lithium; oral
3.3
6.6
30
91
SPAT1059
SPAT
Spirometry at the office
2.3
6.6
59
268
M01AX17
ATC
nimesulide; oral
1.5
6.5
247
1761
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
6.5
259
1866
N02CD01
ATC
erenumab; parenteral
10.1
6.5
12
12
A10AA01
ATC
NA
3.5
6.5
28
81
N06BA04
ATC
methylphenidate; oral
4.2
6.5
23
56
M01AX05
ATC
glucosamine; oral
1.5
6.5
194
1315
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
6.5
60
273
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
6.2
6.5
16
26
C07AA05
ATC
propranolol; systemic
1.6
6.4
179
1192
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
6.4
158
1020
N05BA02
ATC
chlordiazepoxide; systemic
3.1
6.4
32
104
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.9
6.4
24
62
SPAT1307
SPAT
Psychosocial counselling and guidance
2.2
6.3
60
279
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
6.3
117
697
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
6.3
356
2742
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
18.1
6.3
9
5
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
18.1
6.3
9
5
ZXA05
NOMESCO Finland
Left side
1.5
6.3
257
1866
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
6.3
44
174
R06.5
ICD-10 Finland
Mouth breathing
1.9
6.3
89
485
EMB10
NOMESCO Finland
Tonsillectomy
2.3
6.2
54
242
DFF15
NOMESCO Finland
Speech audiometry
3.6
6.2
26
74
J46
ICD-10 Finland
Status asthmaticus
3.6
6.2
26
74
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
6.2
41
159
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.2
301
2260
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.2
288
2143
ACC51
NOMESCO Finland
Release of median nerve
2.0
6.2
70
351
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.1
357
2767
F60.5
ICD-10 Finland
Anankastic personality disorder
7.7
6.1
13
17
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.6
6.1
41
161
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
12.6
6.1
10
8
W19
ICD-10 Finland
Unspecified fall
1.8
6.1
95
536
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.9
6.1
86
471
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.9
6.1
35
124
F61.0
ICD-10 Finland
Mixed personality disorders
4.4
6.0
20
46
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.7
6.0
37
138
B01AB05
ATC
enoxaparin; parenteral
1.4
6.0
310
2350
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.0
211
1481
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.2
6.0
21
51
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
6.0
91
509

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
626
3585
2.18
48.69
3.3
2.4
u/l
59.5
60.4
0.08
594
3298
(3013826) Glucose [Moles/volume] in Serum or Plasma
1064
7476
2.13
47.93
5.3
4.3
mmol/l
6.8
6.7
0.40
1017
6921
(3028707) Methadone [Presence] in Urine by Screen method
80
129
6.46
47.80
5.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
729
4619
2.01
41.63
3.9
3.3
ng/l
45.3
62.9
0.72
551
3217
(3019150) Specific gravity of Urine by Refractometry
470
2560
2.16
40.19
4.4
3.3
kg/l
1.0
1.0
0.71
88
368
(3019550) Sodium [Moles/volume] in Serum or Plasma
1572
13701
2.94
32.55
18.8
14.5
mmol/l
139.7
139.7
0.34
1548
13292
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
623
3986
1.89
32.50
3.6
2.8
u/l
38.6
37.6
0.08
591
3758
(40761535) Cells panel - Urine sediment
199
812
2.64
32.39
3.9
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
204
848
2.60
31.97
3.5
2.3
ml/min/173m2
54.1
64.7
3.60
73
339
(3023103) Potassium [Moles/volume] in Serum or Plasma
1572
13743
2.90
31.54
18.9
14.7
mmol/l
4.0
4.0
1.90
1549
13312
(3013707) Erythrocyte sedimentation rate by Westergren method
1162
9083
1.88
31.19
4.5
3.4
mm/h
11.8
12.0
0.18
1091
8308
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1393
11594
2.11
30.85
5.0
4.0
mu/l
1.9
2.3
1.22
1296
10419
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1530
13240
2.55
30.63
16.2
12.1
mg/l
24.2
26.7
1.95
1252
10190
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
865
6267
1.77
28.97
5.9
5.8
umol/l
11.1
12.1
2.46
830
5935
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1210
9682
1.87
28.92
7.5
6.7
u/l
76.5
78.4
0.99
1143
9025
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1165
9228
1.83
28.60
4.2
3.5
pmol/l
15.0
14.8
1.18
1076
8216
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
826
5925
1.77
28.46
7.3
6.0
mmol/l
1.2
1.2
0.36
718
4756
(3013115) Eosinophils [#/volume] in Blood
843
6089
1.76
28.29
6.1
5.3
e9/l
0.2
0.2
1.04
759
5161
(3024731) MCV [Entitic volume]
1664
15223
5.28
27.42
23.9
17.7
fl
91.1
91.0
0.61
1653
14954
(3026361) Erythrocytes [#/volume] in Blood
1664
15224
5.28
27.40
24.0
17.8
e12/l
4.5
4.6
1.28
1637
14676
(3010813) Leukocytes [#/volume] in Blood
1664
15227
5.27
27.33
24.0
17.8
e9/l
6.9
6.7
1.38
1637
14670
(3000963) Hemoglobin [Mass/volume] in Blood
1664
15228
5.26
27.30
24.1
17.9
g/l
137.0
137.5
0.67
1651
14959
(3034092) Cytoplasmic Ig cells/100 cells in Blood
33
8
41.98
26.82
8.1
23.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
1662
15222
5.01
26.68
23.9
17.7
pg
30.4
30.4
0.54
1652
14952
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1457
12535
2.13
26.48
13.8
12.5
ml/min/173m2
79.8
80.6
0.58
1158
10094
(3007461) Platelets [#/volume] in Blood
1660
15202
4.82
26.40
23.9
17.8
e9/l
243.1
244.0
0.23
1637
14705
(3006315) Basophils [#/volume] in Blood
812
5879
1.73
26.38
5.7
5.1
e9/l
0.0
0.0
1.10
724
4869
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
543
3508
1.80
26.26
2.4
2.0
u/l
225.4
224.8
0.01
513
3267
(3001604) Monocytes [#/volume] in Blood
810
5868
1.73
26.20
5.7
5.1
e9/l
0.6
0.6
0.08
718
4855
(3032080) INR in Blood by Coagulation assay
750
5319
1.73
26.20
9.3
9.4
inr
1.2
1.3
0.24
212
1671
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1484
12875
2.20
26.10
4.9
4.3
mmol/l
6.0
6.0
1.09
1379
11566
(3014051) Protein [Presence] in Urine by Test strip
75
194
4.00
25.95
2.0
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
601
4026
1.76
25.53
3.9
3.0
mmol/l
8.0
8.0
0.01
525
3337
(3019198) Lymphocytes [#/volume] in Blood
829
6079
1.71
25.37
5.7
5.2
e9/l
1.9
1.9
0.20
745
5164
(3037467) Urinalysis macro (dipstick) panel - Urine
1093
8655
1.74
25.08
4.5
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
843
6251
1.69
24.41
5.1
4.3
estimate
0.0
0.0
0.50
128
1301
(3009261) Glucose [Presence] in Urine by Test strip
849
6340
1.68
23.67
4.0
3.2
estimate
0.0
0.0
1.23
122
1235
(3008152) Bicarbonate [Moles/volume] in Arterial blood
172
758
2.41
23.59
8.4
6.5
mmol/l
24.5
24.4
0.18
161
707
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
517
3382
1.76
23.46
3.2
2.8
ng/l
1231.1
1514.7
1.11
449
2907
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1597
14428
2.75
23.39
11.1
8.9
u/l
26.9
27.2
0.19
1562
13808
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1417
12228
1.95
23.15
6.9
5.3
mmol/mol
40.8
39.6
5.15
1329
11165
(3035350) Ketones [Presence] in Urine by Test strip
835
6241
1.66
22.94
4.0
3.2
estimate
0.0
0.0
0.50
123
1276
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
755
5499
1.67
22.92
7.0
5.7
mmol/l
1.2
1.2
0.19
699
4978
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1507
13340
2.14
22.16
4.7
4.1
mmol/l
4.5
4.6
2.62
1408
12245
(3013650) Neutrophils [#/volume] in Blood by Automated count
909
6987
1.65
22.03
8.2
8.2
e9/l
4.3
4.3
0.07
815
5873
(40761511) CBC panel - Blood by Automated count
1564
14091
2.36
21.32
16.2
11.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
791
5924
1.63
20.87
4.4
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
682
4931
1.64
20.69
4.2
3.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
81
258
3.25
20.56
6.8
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1020
8165
1.62
20.20
5.3
3.8
e6/l
1026.3
2568.8
0.80
52
161
(4198724)
27
34
8.05
20.05
4.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1445
12710
1.91
20.03
4.2
3.6
mmol/l
1.3
1.3
0.45
1344
11489
(3022217) INR in Platelet poor plasma by Coagulation assay
243
1310
2.00
20.01
30.3
27.3
inr
1.5
1.4
0.29
20
147
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1489
13237
2.00
19.86
4.7
4.0
mmol/l
1.4
1.4
0.97
1391
12077
(3000330) Specific gravity of Urine by Test strip
136
583
2.45
19.76
2.8
3.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
162
759
2.25
19.21
2.3
2.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1520
13650
2.07
19.11
5.3
4.6
mmol/l
2.7
2.7
1.68
1412
12448
(3045414) Leukocytes [Presence] in Urine
108
421
2.67
19.10
1.8
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
181
890
2.16
19.05
2.4
2.1
ug/l
9.3
8.0
0.17
161
792
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
657
4788
1.61
18.81
1.9
1.8
pmol/l
95.9
92.3
1.09
363
2453
(1001926) Buprenorphine [Presence] in Urine by Screen method
91
331
2.85
18.37
5.7
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
256
1459
1.89
17.78
3.1
1.6
%
1.5
1.4
0.87
204
1279
(3020682) Albumin/Creatinine [Ratio] in Urine
563
4005
1.61
17.54
4.2
3.9
mg/mmol
8.1
7.9
0.03
378
2605
(3016879) Cocaine [Presence] in Urine
103
410
2.61
17.48
5.2
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
731
5578
1.54
16.51
6.2
5.3
%
2.8
2.8
0.31
688
5165
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
412
2751
1.66
16.39
1.8
1.7
pmol/l
64525555.0
34746179.2
0.32
358
2242
(3019309) Folate [Moles/volume] in Red Blood Cells
339
2150
1.72
16.36
1.8
1.7
nmol/l
1249.9
1166.8
0.93
268
1598
(3019069) Monocytes/100 leukocytes in Blood
734
5616
1.54
16.31
6.8
5.6
%
8.8
8.8
0.19
696
5217
(3018010) Neutrophils/100 leukocytes in Blood
739
5674
1.53
16.10
6.0
5.3
%
57.6
58.0
0.42
699
5271
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
224
1261
1.89
16.08
8.0
6.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
531
3796
1.58
15.88
3.4
3.1
mg/l
157.6
232.2
0.26
366
2494
(3016502) Oxygen saturation in Arterial blood
225
1282
1.87
15.54
6.4
7.5
%
95.7
95.6
0.08
216
1236
(3028300) Cannabinoids [Presence] in Urine
106
454
2.42
15.43
5.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
105
448
2.43
15.41
5.2
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
690
5263
1.52
15.25
4.5
4.5
g/l
35.2
35.3
0.08
638
4836
(3022948) Iron [Moles/volume] in Serum or Plasma
287
1773
1.74
15.12
2.8
2.4
umol/l
13.7
13.0
0.98
272
1631
(3027008) Opiates [Presence] in Urine
105
454
2.40
14.97
5.1
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
243
1434
1.81
14.96
6.2
7.2
mmol/l
0.8
0.8
0.01
184
1161
(3002173) Hemoglobin [Mass/volume] in Arterial blood
214
1216
1.87
14.88
6.6
7.8
g/l
125.0
122.1
1.18
202
1176
(3017732) Neutrophils [#/volume] in Blood
143
706
2.12
14.84
3.4
3.2
e9/l
3.9
4.3
1.90
116
553
(3027944) Amphetamines [Presence] in Urine
104
450
2.40
14.81
5.4
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
743
5790
1.50
14.65
6.3
5.4
%
27.4
27.0
0.47
701
5353
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
421
2897
1.60
14.60
2.4
2.0
mg/l
3.1
2.9
1.00
374
2444
(3019060) Gas panel - Arterial blood
159
825
2.02
14.44
5.2
4.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
701
5412
1.50
14.38
6.0
5.4
%
0.7
0.6
0.24
662
5011
(3043409) Potassium [Moles/volume] in Arterial blood
87
353
2.54
14.22
6.2
4.1
mmol/l
3.9
4.0
0.11
81
326
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
364
2445
1.62
13.86
1.6
1.6
mg/l
1.1
1.4
0.94
281
1893
(3029937) Albumin [Presence] in Urine by Test strip
483
3473
1.55
13.70
4.6
3.4
estimate
0.0
0.0
1.54
120
1212
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
600
4537
1.50
13.36
2.3
2.0
nmol/l
77.0
76.3
0.22
537
3997
(3000850) Epithelial cells [#/volume] in Urine
390
2706
1.57
12.85
3.4
2.4
e6/l
4.2
5.3
0.97
354
2354
(3007853) Bacteria identified in Skin by Aerobe culture
222
1332
1.77
12.84
1.8
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
234
1427
1.74
12.79
6.2
7.2
kpa
5.1
5.1
0.11
226
1370
(3027801) Oxygen [Partial pressure] in Arterial blood
234
1427
1.74
12.79
6.2
7.2
kpa
11.7
12.3
1.00
225
1368
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
132
669
2.05
12.77
2.3
3.1
kpa
5.2
5.2
0.09
122
622
(3020191) Ethanol [Moles/volume] in Serum or Plasma
33
79
4.24
12.73
1.7
1.4
promille
1.3
1.6
0.48
22
62
(3047181) Lactate [Moles/volume] in Blood
87
375
2.39
12.52
4.4
5.3
mmol/l
1.4
1.3
0.39
80
322
(3011397) Hemoglobin [Presence] in Urine by Test strip
385
2678
1.57
12.50
4.1
3.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
127
645
2.05
12.22
2.3
3.0
mmol/l
1.4
2.3
2.49
85
459
(3009343) pH of Capillary blood
129
660
2.03
12.17
2.3
3.1
ph
7.4
7.4
0.18
22
133
(3023368) Bacteria identified in Blood by Culture
474
3483
1.50
11.86
4.1
4.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
258
1651
1.66
11.76
1.3
1.2
u/ml
7.0
11.8
0.90
92
623
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1000
8477
1.44
11.64
3.9
2.6
u/l
51.6
49.9
0.18
953
7843
(3004789) Transferrin [Mass/volume] in Serum or Plasma
259
1665
1.66
11.59
2.8
2.4
g/l
2.4
2.3
1.70
248
1510
(3001122) Ferritin [Mass/volume] in Serum or Plasma
643
5044
1.44
11.40
3.1
2.6
ug/l
139.3
153.1
0.69
604
4622
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
286
1892
1.62
11.40
1.9
1.7
—
—
—
0
0
(3020891) Body temperature
104
503
2.14
11.39
7.0
4.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
472
3491
1.49
11.35
3.2
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
263
1707
1.64
11.32
2.3
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
402
2882
1.52
11.23
1.5
1.5
nmol/l
19.7
20.0
0.15
345
2388
(3013512) EKG study
468
3495
1.47
10.60
4.2
3.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
74
321
2.36
10.53
2.2
2.9
mmol/l
24.5
24.7
0.18
68
291
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
243
1576
1.63
10.45
2.8
2.4
%
23.6
23.2
0.13
205
1340
(3030981) Hyaline casts [#/volume] in Urine by Automated count
122
648
1.95
10.37
3.5
2.4
e6/l
0.2
0.3
0.65
122
629
(3018095) Leukocytes [#/volume] in Urine
586
4592
1.42
10.16
4.2
3.4
e6/l
135.4
133.2
0.02
475
3164
(3048689) Calprotectin [Mass/mass] in Stool
193
1194
1.70
9.94
2.2
2.2
ug/g
176.7
163.3
0.11
148
950
(3026493) Urate [Moles/volume] in Serum or Plasma
442
3301
1.46
9.91
2.7
2.5
umol/l
3180.0
6974.5
1.33
382
2832
(3018418) pH of Serum or Plasma
494
3769
1.44
9.88
5.0
4.0
ph
7.4
7.4
0.57
79
868
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
136
763
1.85
9.79
1.6
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
110
578
1.97
9.65
3.5
3.1
mmol/l
25.1
24.9
0.20
102
559
(3044640) Blood type and Crossmatch panel - Blood
516
3996
1.42
9.42
2.5
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
520
4038
1.41
9.33
3.8
3.0
e6/l
51.6
127.0
1.56
440
2984
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
65
282
2.36
9.28
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
230
1515
1.60
9.24
6.4
5.5
mmol/l
1.0
1.0
0.35
218
1420
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
73
334
2.24
9.22
2.5
2.5
ug/min
69.1
106.2
0.61
43
209
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
261
1782
1.55
8.97
1.3
1.2
iu/ml
61.2
34.7
0.41
82
539
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
93
474
2.02
8.91
2.2
2.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
39
134
2.96
8.84
5.8
5.2
umol/l
337.4
344.2
0.10
34
117
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
324
2333
1.48
8.63
1.3
1.2
u/ml
1.9
1.9
0.02
100
622
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
614
4976
1.37
8.31
5.1
4.3
%
22.2
21.8
0.23
307
2500
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
204
1345
1.59
8.14
1.9
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
91
479
1.95
7.98
2.1
1.9
ug/l
1.2
3.3
1.43
81
427
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
204
1353
1.58
7.93
1.8
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
54
232
2.37
7.92
5.5
1.6
nmol/l
0.8
0.8
0.09
46
209
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
111
626
1.83
7.89
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
105
3.09
7.87
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
235
1619
1.52
7.70
7.1
7.0
mmol/l
104.1
104.5
0.53
227
1582
(3007164) IgA [Mass/volume] in Serum or Plasma
288
2072
1.47
7.64
1.6
1.4
g/l
2.6
2.6
0.07
183
1261
(3041096) Erythrocytes [Presence] in Urine by Automated
466
3655
1.38
7.61
3.5
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
209
1410
1.55
7.54
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
912
7923
1.33
7.46
2.7
2.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
97
536
1.86
7.37
1.5
1.2
u/ml
205.6
237.5
0.21
92
483
(3004809) Band form neutrophils/100 leukocytes in Blood
40
155
2.62
7.30
3.4
3.0
%
1.3
1.4
0.09
35
124
(42870588) Differential panel, method unspecified - Blood
512
4100
1.36
7.28
5.8
5.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
205
1390
1.54
7.22
1.3
1.3
titre
336.8
495.7
1.41
38
262
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
98
547
1.84
7.22
1.3
1.2
au/ml
57.8
73.3
—
5
26
(3025941) Bacteria identified in Stool by Culture
108
622
1.79
7.18
1.3
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
80
3.28
7.12
3.6
2.9
%
59.1
58.4
0.06
19
51
(3018677) aPTT in Platelet poor plasma by Coagulation assay
271
1954
1.46
7.08
1.8
2.0
s
29.9
30.1
0.19
265
1903
(3002385) Erythrocyte distribution width [Ratio]
1244
11349
1.36
7.05
19.0
15.4
%
13.7
13.6
0.32
1228
11047
(4010399)
127
771
1.70
7.03
1.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
467
3708
1.36
6.96
3.6
3.0
e6/l
0.4
0.5
0.90
394
2685
(3027945) Reticulocytes/100 erythrocytes in Blood
201
1369
1.53
6.93
3.0
2.4
%
1.6
1.7
0.44
187
1205
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
190
1280
1.55
6.89
4.6
4.3
%
31.7
32.4
0.34
133
810
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
116
695
1.72
6.74
1.2
1.2
iu/ml
148.8
159.9
0.10
36
266
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
297
2200
1.42
6.69
2.7
2.8
e6/l
1.0
1.2
0.51
219
1154
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
727
6180
1.31
6.69
5.5
4.9
ug/l
2.1
3.1
3.68
666
5501
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
105
614
1.76
6.65
4.1
3.6
pmol/l
4.5
4.5
0.02
94
540
(40758558) Short blood count panel - Blood
379
2936
1.37
6.56
7.1
6.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1349
12516
1.38
6.49
15.4
13.3
%
40.5
40.2
0.58
876
8917
(3020779) Urea [Moles/volume] in Serum or Plasma
164
1088
1.56
6.37
7.8
6.2
mmol/l
10.4
10.5
0.06
155
1038
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
95
547
1.78
6.35
2.6
2.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
162
1075
1.56
6.29
1.8
1.9
g/l
0.2
0.2
0.07
147
988
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
92
2.97
6.28
5.7
3.3
—
—
—
0
0
(4133840)
15
34
4.44
6.24
1.4
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
506
4131
1.32
6.12
2.7
3.5
mmol/l
2.3
2.4
2.17
451
3611
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
117
724
1.66
6.05
7.1
9.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
59
296
2.03
5.99
1.9
2.1
u/l
9297.5
5077.9
0.38
28
120
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
373
2924
1.35
5.92
2.4
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
78
433
1.84
5.90
2.6
3.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
46
212
2.20
5.82
2.8
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
25
86
2.94
5.74
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
156
2.40
5.74
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
307
2353
1.37
5.61
3.7
3.4
ng/l
556.2
578.7
0.04
256
1913
(44813793)
20
61
3.31
5.59
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
145
967
1.55
5.52
4.1
3.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
85
495
1.75
5.50
4.6
4.7
%
0.9
0.9
0.06
80
462
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
86
503
1.75
5.49
4.6
4.5
%
1.7
1.6
0.15
81
470
(40768804) Tissue Pathology biopsy report
573
4816
1.29
5.45
2.2
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
177
1235
1.48
5.45
1.3
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
98
599
1.67
5.34
3.4
2.5
%
0.7
0.6
1.71
90
572
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
121
780
1.59
5.34
4.0
4.0
ng/l
98.1
98.2
0.00
108
660
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
29
113
2.59
5.31
1.2
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
32
131
2.47
5.30
1.2
1.3
nmol/l
0.6
0.6
0.04
32
125
(3036481) Cortisol [Moles/volume] in Serum or Plasma
141
950
1.53
5.14
2.5
2.3
nmol/l
386.7
382.9
0.07
130
883
(3014271) Vancomycin [Susceptibility]
12
27
4.47
5.04
2.3
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
47
233
2.05
4.98
2.0
2.3
umol/l
29.4
34.6
0.78
40
193
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
94
2.68
4.92
1.6
1.4
e6/l
25289.7
81446.6
0.39
16
64
(3004119) Hemoglobin [Mass/volume] in Venous blood
121
796
1.56
4.91
3.5
3.0
g/l
131.8
130.3
0.31
115
774
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
51
3.36
4.89
1.4
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
51
3.36
4.89
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
258
1965
1.37
4.88
3.1
3.0
mmol/l
0.8
0.8
0.23
243
1851
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
33
143
2.33
4.86
1.3
1.3
mmol/l
10.1
7.3
—
10
97
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
150
1037
1.49
4.84
2.3
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
124
828
1.54
4.72
8.2
9.0
%
0.7
0.6
1.81
124
822
(36304419) Bacteria [Presence] in Urine
436
3600
1.28
4.65
3.5
3.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
22
80
2.77
4.62
2.0
2.0
e9/l
1.0
1.1
0.57
14
56
(3024263) Appearance of Synovial fluid
17
53
3.23
4.62
1.6
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
5
14.05
4.57
1.3
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
142
985
1.48
4.52
2.2
2.7
e9/l
68.3
66.6
0.26
120
688
(42529406) Shigella sp [Presence] in Stool by Culture
55
302
1.85
4.38
1.3
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
162
1164
1.43
4.31
4.3
3.5
kpa
5.8
5.8
0.18
156
1136
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
393
1.73
4.30
3.0
2.1
—
—
—
0
0
(3001729) Color of Synovial fluid
8
9
8.92
4.28
2.1
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
62
357
1.76
4.24
1.1
1.2
u/ml
0.2
1.2
—
8
39
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
94
605
1.59
4.23
2.1
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
46
3.28
4.19
2.1
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
41
3.43
4.18
3.4
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
173
1266
1.41
4.16
1.9
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
178
1311
1.40
4.12
2.9
2.4
umol/l
5.7
9.4
4.63
157
1131
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
301
1.82
4.12
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
301
1.82
4.12
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
160
1159
1.42
4.08
4.3
3.5
mmol/l
1.8
1.7
0.10
130
935
(3004775) Volume in Urine collected for unspecified duration
26
110
2.38
4.08
2.0
2.0
ml
843.1
669.8
0.90
15
68
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
48
259
1.88
4.06
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
48
260
1.87
4.01
1.8
1.6
e6/l
18482.7
15973.0
0.12
35
181
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
463
1.65
4.01
2.0
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
32
150
2.16
3.97
1.9
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
60
353
1.73
3.84
3.8
3.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
279
1.82
3.82
1.5
1.5
ug/g
261.0
248.9
0.13
31
167
(3000494) Fungus identified in Specimen by Culture
176
1312
1.38
3.81
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
83
2.55
3.80
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
60
2.85
3.79
1.4
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
38
194
1.98
3.79
1.1
1.2
—
40.0
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
38
194
1.98
3.79
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
68
416
1.66
3.78
1.9
1.7
nmol/l
43.6
39.8
0.58
68
406
(3003327) Ova and parasites identified in Stool by Light microscopy
52
295
1.79
3.77
1.7
1.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
25
108
2.33
3.76
1.2
1.4
pmol/l
65.4
75.4
—
5
34
(3004716) Salmonella sp identified in Stool by Organism specific culture
85
553
1.57
3.69
1.2
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
50
3.02
3.69
3.4
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
248
1958
1.31
3.67
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
63
381
1.68
3.66
2.0
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
47
261
1.82
3.66
1.9
2.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
164
1218
1.38
3.63
2.3
2.0
nmol/l
12.9
13.1
0.12
146
1085
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
104
2.33
3.60
1.3
1.3
mmol/l
9.2
13.4
—
6
19
(3017704) Immunofixation for Urine
15
51
2.96
3.57
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1024
9452
1.21
3.57
4.2
3.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
86
2.46
3.55
1.3
1.3
—
—
—
0
0
(4306422)
27
125
2.18
3.49
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
87
2.43
3.47
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
87
2.43
3.47
1.3
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
120
2.18
3.39
1.8
1.4
%
30.5
28.3
0.13
17
65
(40757373) Influenza virus identified in Isolate
7
10
7.02
3.36
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
156
1165
1.37
3.36
2.3
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
255
1.79
3.31
1.3
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
136
996
1.40
3.29
4.1
3.4
%
0.8
1.0
0.46
50
283
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
26
122
2.15
3.26
1.2
1.3
nmol/l
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
59
363
1.65
3.25
1.7
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
73
2.48
3.13
1.5
1.2
u/ml
1.7
1.3
—
7
33
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
67
2.55
3.13
1.9
1.9
%
15.5
12.7
0.30
11
25
(3025159) Blasts/100 leukocytes in Blood
125
912
1.40
3.11
3.9
3.5
%
0.0
0.1
0.65
41
236
(3028026) IgM [Mass/volume] in Serum or Plasma
88
603
1.48
3.06
2.0
2.0
g/l
1.5
1.4
0.15
83
553
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
146
2.00
3.06
1.4
1.6
%
63.0
66.2
0.20
18
90
(44790048)
23
106
2.19
3.03
1.3
1.3
—
—
—
0
0
(44790047)
23
106
2.19
3.03
1.3
1.3
—
—
—
0
0
(44806118)
23
106
2.19
3.03
1.3
1.3
—
—
—
0
0
(44790049)
23
106
2.19
3.03
1.3
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
55
339
1.64
3.03
3.3
3.0
mg/l
37.3
28.7
0.78
40
228
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
50
301
1.68
3.01
1.6
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
40
3.01
2.97
6.7
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
40
3.01
2.97
6.8
2.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
132
981
1.37
2.95
3.6
2.5
g/l
66.9
66.2
0.53
121
894
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
88
2.29
2.94
1.4
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
179
1399
1.31
2.87
4.0
3.9
u/l
235.1
247.0
0.65
166
1332
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
89
2.26
2.87
1.4
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
23
109
2.13
2.85
1.3
1.2
u/l
38.5
20.4
1.07
18
101
(40760892) CBC W Ordered Manual Differential panel - Blood
329
2774
1.23
2.82
4.8
4.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
130
2.02
2.81
1.2
1.1
u/ml
3.4
3.3
0.03
12
50
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
36
3.07
2.81
1.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
36
3.07
2.81
1.5
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
18
4.46
2.79
1.4
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
314
2638
1.23
2.79
3.3
2.6
mosm/kgh2o
557.4
573.4
0.62
278
2239
(3006184) Hemoglobin [Mass/volume] in Capillary blood
53
332
1.62
2.76
1.7
2.2
g/l
134.0
129.5
0.68
45
254
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
10
6.02
2.70
1.5
2.2
umol/l
18.6
17.3
—
6
10
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
96
688
1.42
2.68
1.8
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
107
783
1.39
2.65
3.0
2.2
—
—
—
0
0
(3036489) Thrombin time
65
433
1.52
2.62
1.7
1.9
s
20.5
21.8
1.51
56
387
(44806420)
14
55
2.56
2.61
2.9
2.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
49
307
1.61
2.57
1.7
1.3
u/l
9.1
7.9
0.29
40
254
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
20
4.01
2.57
9.6
5.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
252
2086
1.24
2.56
3.0
2.9
e6/l
1.6
1.8
0.39
174
1044
(3021440) Promyelocytes/100 leukocytes in Blood
125
944
1.35
2.56
4.2
3.4
%
0.0
0.2
2.08
45
265
(3009445) Proteinase 3 Ab [Units/volume] in Serum
67
452
1.50
2.56
1.3
1.7
—
21.2
—
0
13
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
81
2.24
2.54
2.1
2.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
56
2.51
2.53
1.7
1.8
e6/l
704.3
621.4
—
7
21
(46235355) HIV 1 and 2 tests - Meaningful Use set
245
2025
1.25
2.53
2.1
1.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
33
3.04
2.52
1.5
1.4
umol/l
125.2
110.8
—
5
20
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
116
2.00
2.46
3.1
2.0
mg/l
33.0
21.3
—
6
38
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
188
1.77
2.46
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
57
2.47
2.45
1.4
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
57
2.47
2.45
1.4
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
27
3.35
2.39
2.0
2.0
—
—
—
0
0
(4024509)
15
64
2.36
2.39
1.7
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
64
2.36
2.39
2.1
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
107
799
1.36
2.37
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
97
2.07
2.37
1.2
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
8
6.26
2.37
1.2
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
140
1.87
2.32
1.0
1.1
u/ml
5.1
8.1
0.42
12
62
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
163
1297
1.28
2.32
3.4
4.6
ug/l
4.3
16.1
3.35
134
1054
(4062490)
17
78
2.19
2.31
1.2
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
114
1485
0.75
2.30
5.1
3.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
59
2.38
2.29
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
59
2.38
2.29
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
59
2.38
2.29
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
126
971
1.32
2.28
1.7
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
224
1.67
2.25
1.5
1.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.34
2.22
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.34
2.22
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.34
2.22
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
172
1.76
2.21
1.2
1.1
u/ml
1.3
1.5
0.04
13
57
(3044941) Cell count panel - Synovial fluid
35
210
1.68
2.21
1.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
142
1118
1.29
2.21
7.3
8.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
30
173
1.75
2.17
7.5
6.0
mmol/l
7.5
7.2
0.19
25
156
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
24
129
1.87
2.17
1.1
1.1
%
112.4
116.7
0.17
19
113
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
87
2.08
2.17
1.4
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
19
3.69
2.15
1.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
120
927
1.32
2.15
3.7
3.3
%
0.7
0.7
0.04
37
223
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72
514
1.42
2.11
1.1
1.0
—
—
—
0
0
(4146454)
11
43
2.57
2.09
2.7
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
515
1.42
2.09
1.6
1.7
g/l
1.4
1.5
0.23
60
436
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
10
5.01
2.07
1.4
2.0
umol/l
43.0
35.3
—
5
10
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
10
5.01
2.07
1.6
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
96
1.99
2.05
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
204
1694
1.23
2.04
1.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
208
1.65
2.02
1.4
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
26
3.09
2.01
1.1
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
83
2.06
2.01
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
62
435
1.44
2.01
2.7
2.0
u/l
40.1
37.4
0.42
55
372
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
32
2.82
2.00
2.8
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
21
3.34
1.96
2.1
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
90
677
1.35
1.95
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
355
1.48
1.94
1.5
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
33
203
1.64
1.93
1.3
1.4
e6/l
13.2
31.8
0.48
26
148
(3003694) ABO and Rh group [Type] in Blood
439
3926
1.16
1.91
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
58
2.25
1.91
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
37
236
1.58
1.88
1.9
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
114
1.85
1.87
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
107
1.88
1.86
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
28
2.87
1.86
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
41
269
1.54
1.85
2.3
1.8
iu/l
3.5
5.4
—
10
94
(3044927) Protein electrophoresis panel - Urine
18
93
1.95
1.85
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
270
1.53
1.82
1.5
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
12
4.18
1.82
1.4
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
38
246
1.56
1.82
1.4
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
29
2.77
1.79
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
93
1196
0.76
1.76
1.5
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
67
2.10
1.76
1.1
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
12
54
2.23
1.74
1.3
2.1
u/l
216.5
195.9
0.46
12
54
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
110
1.83
1.73
1.2
1.0
u/ml
9.8
2.9
—
8
31
(40768443) Skin Pathology biopsy report
68
500
1.37
1.73
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
24
2.92
1.72
3.0
2.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
13
3.85
1.71
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
467
1.38
1.71
3.1
3.5
u/ml
58.9
3601.3
0.95
59
399
(3037121) Protein [Mass/volume] in Urine
50
350
1.44
1.68
2.3
3.1
g/l
0.5
0.4
0.15
20
165
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
48
334
1.45
1.66
5.1
2.8
mg/l
1.9
1.6
0.61
39
303
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
134
1.73
1.66
1.1
1.0
u/ml
1.0
2.3
—
6
20
(3032773) Endomysium IgG Ab [Titer] in Serum
18
97
1.86
1.66
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
143
1.69
1.61
1.0
1.1
u/ml
0.6
1.0
—
10
56
(1616796) Gas panel - Central venous blood
51
362
1.42
1.60
2.6
4.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
397
1.40
1.58
3.9
2.9
mg/l
33.9
58.1
0.85
46
293
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
11
50
2.21
1.57
1.1
2.6
%
41.0
38.1
—
6
16
(3034860) Kappa light chains.free [Mass/volume] in Serum
55
398
1.39
1.56
3.9
2.9
mg/l
131.2
68.2
0.32
46
290
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
192
1.57
1.54
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
59
792
0.74
1.53
1.3
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
133
1093
1.24
1.51
1.5
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
42
291
1.45
1.51
3.5
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
123
1.72
1.51
1.5
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
21
2.86
1.50
1.3
1.2
—
—
—
0
0
(4034850)
70
531
1.33
1.49
11.9
9.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
139
1.66
1.48
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
276
1.46
1.47
1.7
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
22
2.73
1.43
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
254
1.47
1.41
1.4
1.8
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
81
1.86
1.40
1.1
1.1
mmol/l
2.3
1.9
0.60
15
75
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
214
1.50
1.38
1.0
1.2
u/ml
2.0
9.9
—
8
28
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
400
1.36
1.36
2.9
2.4
g/l
3.7
3.9
0.40
37
300
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
400
1.36
1.36
2.9
2.4
g/l
7.5
7.4
0.08
39
315
(3044290) Cell count panel - Cerebral spinal fluid
30
199
1.52
1.35
1.1
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
401
1.36
1.35
2.9
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
42
2.15
1.33
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
47
343
1.38
1.31
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
121
1.66
1.31
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
282
0.60
1.30
1.4
1.5
—
—
—
0
0
(4027681)
9
43
2.10
1.30
1.2
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
18
2.78
1.28
1.8
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
68
528
1.30
1.27
3.4
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
229
0.56
1.25
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
36
2.23
1.24
2.9
2.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
155
1.56
1.23
1.9
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
85
1.77
1.23
2.1
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
63
1.91
1.23
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
78
1.80
1.21
1.8
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
40
289
1.39
1.20
1.5
1.2
miu/ml
246.1
227.1
0.10
14
129
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
109
1.66
1.19
1.5
2.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
26
2.31
1.18
2.8
6.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
173
1.51
1.18
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
190
1.48
1.16
1.4
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
39
2.06
1.15
1.4
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
234
0.59
1.13
1.3
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
26
175
1.49
1.13
1.5
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
20
127
1.58
1.11
1.5
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
372
1.33
1.10
3.1
2.5
g/l
3.2
3.2
0.28
37
310
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
21
2.38
1.09
1.4
1.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
21
2.38
1.09
1.6
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
27
185
1.47
1.08
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
120
1.59
1.08
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
210
1.44
1.08
2.4
2.9
nmol/l
0.9
0.8
0.39
23
172
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
40
296
1.36
1.06
1.8
1.7
iu/ml
18.2
0.3
0.74
11
61
(3039443) Prostate specific Ag panel - Serum or Plasma
24
349
0.68
1.06
2.2
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
137
1.54
1.05
1.3
1.2
u/ml
2.3
3.5
—
8
47
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
33
2.13
1.05
1.6
1.2
umol/l
22.6
30.4
—
7
33
(3011648) Oxygen content in Venous blood
6
121
0.49
1.05
2.8
2.1
%
8.6
11.3
—
6
121
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
265
0.64
1.05
1.3
1.4
—
—
—
0
0
(4094501)
47
358
1.32
1.04
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
32
229
1.40
1.04
1.0
1.2
—
55.3
—
0
8
(3021589) Normoblasts [#/volume] in Blood
618
5829
1.09
1.03
10.0
9.7
e9/l
0.0
0.0
1.67
521
4620
(3002256) Pathology report gross observation
195
1724
1.15
1.03
1.4
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
26
179
1.46
1.03
1.4
1.3
mmol/l
60.8
62.1
0.05
20
137
(3052851) Hemolysis interference index of Serum or Plasma
52
403
1.30
1.03
3.5
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
121
1032
1.19
1.01
2.3
2.4
ng/l
162.5
192.5
0.65
113
962
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
53
1.89
1.01
1.1
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
226
0.62
1.01
1.3
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
48
1.88
1.00
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(4268621)
14
84
1.67
0.98
2.4
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
173
1.45
0.97
1.2
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
54
1.86
0.96
7.6
3.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
50
1.80
0.96
2.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
69
1.74
0.96
1.9
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
69
1.74
0.96
1.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
69
1.74
0.96
1.9
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
101
1.59
0.93
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
268
0.67
0.92
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
118
1367
0.85
0.92
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
393
3649
1.10
0.91
3.0
3.0
ug/l
0.7
0.8
0.75
258
2397
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
78
1.67
0.91
2.2
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
267
0.67
0.91
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
135
1.49
0.89
1.3
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
43
333
1.30
0.88
3.4
2.5
g/l
37.3
37.2
0.04
37
293
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
265
0.68
0.88
1.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
111
1.54
0.87
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
40
307
1.31
0.87
1.4
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
15
95
1.58
0.87
1.1
1.1
nmol/l
326.3
388.4
—
10
81
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
834
1.19
0.87
1.6
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
30
2.00
0.87
2.7
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
30
2.00
0.87
2.7
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
30
2.00
0.87
2.7
2.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
64
1.72
0.86
1.8
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
179
1.40
0.84
1.4
1.2
u/ml
247.5
276.5
0.12
15
113
(3051611) Lipemic interference index of Serum or Plasma
20
137
1.47
0.84
2.9
2.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
222
1.36
0.84
1.9
1.5
—
—
—
0
0
(4281824)
8
137
0.58
0.83
1.4
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
391
3647
1.09
0.83
1.7
1.6
mmol/l
1.4
1.3
0.11
344
2910
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
121
1.49
0.82
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
2316
1.11
0.79
2.2
3.3
mmol/l
2.4
2.5
3.50
226
2018
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
149
1322
1.14
0.79
1.4
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
25
0.00
0.79
0.0
5.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
37
286
1.30
0.79
1.2
1.2
titre
92.0
129.5
—
5
22
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
156
1.42
0.79
1.2
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
385
1.25
0.77
3.1
2.5
g/l
10.6
10.2
0.23
42
336
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
140
1.43
0.77
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
200
1.36
0.76
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
219
0.68
0.73
2.9
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
25
2.00
0.72
3.0
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
25
2.00
0.72
3.0
2.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
76
1.58
0.71
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
26
1.93
0.70
3.0
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
79
675
1.18
0.70
7.0
9.8
mmol/l
23.5
24.4
1.49
69
644
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
164
1477
1.12
0.70
1.7
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
135
1.41
0.69
1.3
1.3
pmol/l
210.0
234.6
0.18
14
102
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
85
1.53
0.69
1.2
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
27
1.85
0.68
1.4
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
42
1.67
0.68
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
31
240
1.30
0.67
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
43
1.63
0.67
2.7
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
44
359
1.23
0.64
2.1
2.4
%
17.2
16.1
1.41
29
173
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
2.0
2.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
79
1.52
0.62
1.5
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
245
0.73
0.62
1.3
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
3.0
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
0
20
0.00
0.60
0.0
1.5
—
12.8
—
0
14
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
105
1.43
0.60
6.6
5.4
u/ml
48.6
49.4
—
6
29
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
44
367
1.20
0.54
3.4
2.6
g/l
0.8
1.1
0.29
37
314
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
205
1.27
0.52
1.4
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
117
1.37
0.52
1.2
1.0
u/ml
1.1
3.5
—
8
34
(3016038) Potassium [Moles/volume] in Urine
9
63
1.43
0.52
1.2
1.1
mmol/l
45.3
41.8
—
9
57
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
37
305
1.22
0.52
3.8
2.6
g/l
0.0
0.0
0.00
32
278
(3024928) Oxygen saturation in Venous blood
22
281
0.78
0.51
5.1
2.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
67
1.50
0.49
9.0
7.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
225
1.25
0.49
4.4
3.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
46
1.52
0.48
1.7
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
119
1.35
0.48
2.1
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
102
1.38
0.47
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
85
1.41
0.47
1.5
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
173
1.28
0.46
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
38
319
1.20
0.46
3.7
2.6
g/l
0.0
0.0
0.80
33
291
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
49
1.43
0.46
2.7
3.6
u/ml
663.1
971.5
—
7
49
(3034770) Mitochondria Ab [Titer] in Serum
34
283
1.21
0.45
1.1
1.2
—
1571.3
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
362
0.83
0.44
1.6
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
247
1.22
0.44
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
211
1.24
0.43
1.8
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
14
104
1.35
0.43
1.9
1.4
mosm/kgh2o
280.0
280.5
0.03
14
85
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
32
1.56
0.42
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
316
0.82
0.42
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
7.9
—
0
8
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
43
497
0.86
0.40
1.3
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
34
1.47
0.40
1.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
34
1.47
0.40
5.8
6.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
1.6
1.6
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
17.4
—
0
12
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
35
1.43
0.39
1.4
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
106
0.66
0.39
1.4
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
19
0.00
0.39
0.0
2.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
48
547
0.87
0.38
1.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
197
1.22
0.37
1.9
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
71
1.27
0.36
1.6
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
168
0.77
0.35
2.1
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
99
1.32
0.35
2.5
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
199
1.21
0.35
1.4
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
181
1.22
0.34
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
46
405
1.14
0.34
1.7
1.3
iu/l
22.6
24.8
0.23
36
344
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
44
1.36
0.34
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
172
1.22
0.34
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
416
1.13
0.33
2.2
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
90
0.67
0.32
1.0
1.4
g/l
0.9
1.0
—
6
90
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
164
1.22
0.32
4.3
2.6
—
5107.2
—
0
10
(40768441) Liver Pathology biopsy report
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
137
1.24
0.32
1.3
1.4
—
—
—
0
0
(4035726)
110
1181
0.93
0.31
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
53
1.32
0.31
1.1
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
53
1.32
0.31
1.1
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
50
450
1.11
0.28
1.7
1.7
mg/l
2.5
2.6
0.06
31
306
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
67
614
1.09
0.27
5.1
3.9
mmol/l
24.0
24.1
0.08
51
553
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
95
1.27
0.26
1.3
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
118
1114
1.06
0.24
3.3
2.3
u/l
46.6
43.6
0.10
103
953
(3035320) C reactive protein [Mass/volume] in Body fluid
11
87
1.27
0.24
1.8
2.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
189
1.17
0.24
1.8
1.5
u/ml
127.8
105.9
—
5
39
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
39
1.28
0.23
3.4
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
181
1.16
0.22
1.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
200
1.15
0.22
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
135
0.81
0.22
3.3
3.2
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
11
0.00
0.21
0.0
1.2
—
0.1
—
0
6
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
1.5
—
0
11
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
1.0
—
0
5
(40768800) Prostate Pathology biopsy report
45
411
1.10
0.21
1.3
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
5.2
—
0
12
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
113
0.80
0.20
1.3
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
174
1.15
0.19
1.2
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
6
51
1.18
0.19
1.0
1.0
—
0.6
—
0
10
(3006653) Thiamine [Moles/volume] in Blood
6
51
1.18
0.19
1.0
1.2
nmol/l
124.7
132.0
—
6
51
(3000492) Spirometry study
129
1233
1.05
0.19
1.5
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
143
0.84
0.18
2.3
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
179
1730
1.04
0.17
4.1
3.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
67
0.75
0.17
1.4
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
167
1.14
0.17
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
34
311
1.10
0.16
1.4
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
116
1210
0.96
0.16
4.2
3.9
mmol/l
1.2
1.2
1.01
103
1031
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
72
1.11
0.16
5.0
1.8
nmol/l
21.8
19.2
—
8
66
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
235
1.11
0.15
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
513
5205
0.98
0.14
3.6
2.9
—
—
—
0
0
(1002224) Polysomnography panel
48
511
0.94
0.14
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
343
0.93
0.11
1.8
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
29
269
1.08
0.11
1.7
1.8
mmol/l
2.2
1.7
0.89
29
263
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
270
0.92
0.10
1.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
300
0.93
0.10
1.3
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
135
0.89
0.09
1.4
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
166
0.90
0.09
2.1
1.4
e6/l
1530.0
1160.9
—
10
97
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
58
1.03
0.08
4.7
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
318
0.94
0.08
3.2
3.6
%
54.5
57.9
0.73
30
318
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
66
1.06
0.08
1.7
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
68
1.03
0.07
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
68
1.03
0.07
3.9
3.4
—
—
—
0
0
(4211845)
6
71
0.84
0.07
1.3
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
9
85
1.06
0.07
1.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.06
1.6
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
94
0.85
0.06
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
94
0.85
0.06
1.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
25
236
1.06
0.06
1.4
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
331
3341
0.99
0.05
4.4
3.6
%
86.3
87.2
0.24
322
3278
(3010421) pH of Blood
44
427
1.03
0.04
3.8
4.7
ph
7.4
7.4
0.01
39
381
(3012501) Base excess in Blood by calculation
39
383
1.02
0.01
3.9
4.7
mmol/l
2.6
2.7
0.04
29
251
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
447
0.98
0.01
2.5
2.7
u/ml
0.3
0.3
0.33
24
229
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
306
0.98
0.00
2.7
3.2
e9/l
3.7
4.2
1.10
30
306
(3025130) Human papilloma virus identified in Specimen
12
125
0.96
0.00
1.9
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
15
145
1.03
0.00
1.1
1.0
g/l
1.5
1.5
0.29
15
128
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
185
1.03
0.00
1.3
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
119
1.01
0.00
1.1
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
15
146
1.03
0.00
1.7
1.3
mmol/l
6.7
6.0
0.58
15
137
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
254
0.98
0.00
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
254
0.98
0.00
1.4
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
103
0.97
0.00
1.5
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
117
1.03
0.00
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
167
1.02
0.00
1.7
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
57
0.88
0.00
2.0
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
69
0.87
0.00
6.7
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
62
0.97
0.00
1.0
1.3
u/l
95.3
324.8
—
6
57
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
59
0.85
0.00
1.2
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.7
—
0.4
—
0
7
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.1
iu/ml
69.7
180.9
—
5
52
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
58
0.86
0.00
1.0
1.4
—
54.3
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
82
0.98
0.00
1.1
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.6
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
7
78
0.90
0.00
1.6
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
292.1
—
0
8
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
526.8
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
8
86
0.93
0.00
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
82
0.98
0.00
2.6
2.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
110
1.00
0.00
1.3
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
27.0
—
0
8
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
19.4
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO – Examination and encounter for administrative purposes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).